Nanosonics Limited
OTC: NNCSF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Michael C. Kavanagh
- Employees
- 466
- Headquarters
- Macquarie Park, Australia
- IPO year
- 2012
- Market cap
- $762.2M
- Website
- https://www.nanosonics.com.au
Loading NNCSF…
Loading profile data…Frequently asked questions about NNCSF
What does Nanosonics Limited (NNCSF) do?
Nanosonics Limited, in conjunction with its subsidiaries, functions as an infection prevention enterprise, serving both Australian and international markets. The company's core activities involve the production and supply of the trophon ultrasound probe disinfector, alongside its complementary consumables and accessories. Furthermore, Nanosonics...
Where does NNCSF trade?
Nanosonics Limited (NNCSF) trades on the Other OTC.
What sector is NNCSF in?
Nanosonics Limited (NNCSF) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Nanosonics Limited?
Michael C. Kavanagh is the chief executive officer of Nanosonics Limited (NNCSF).
Where is Nanosonics Limited headquartered?
Nanosonics Limited is headquartered in Australia.
Does NNCSF pay a dividend?
Nanosonics Limited (NNCSF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NNCSF go public?
Nanosonics Limited (NNCSF) completed its initial public offering in 2012.